Harvest One Cannabis Inc. (“Harvest One” or the “Company”) (TSXV:HVT; OTCQX:HRVOF), is excited to announce that strategy and culture veteran Deb Milimaka Miles will be joining the Company as Chief Administrative Officer and Chief People Officer.

The Chief Administrative Officer (CAO) & Chief People Officer (CPO) will assist with developing, communicating, executing, and sustaining strategic initiatives. As the pace of change accelerates within organizations, particularly within the cannabis sector, the CAO & CPO will ensure that Harvest One maintains a clear focus on the integration of people and culture across the organization. Utilizing her extensive experience gained from previous senior HR executive positions at Loblaw and SMART Technologies, as well as in the financial sector, Deb will play a key role in the overall company strategy from an organizational, culture and vision point of view. The CAO & CPO will be responsible for managing the administration and integration of people and culture for Harvest One, its subsidiaries and multiple brands as they expand across Canada and around the world.


“We are very excited to have Deb join Harvest One as an officer of the company.  The rapid pace of expansion and M&A activity in this industry, with ever more complex teams across Canada and around the globe, requires a dedicated focus on people, culture and integration, and I can think of no better person to lead that effort than Ms. Milimaka Miles,” said Grant Froese, Chief Executive Officer of Harvest One.  “Her depth of experience in transforming teams, driving process efficiencies, and integrating cultures across acquisitions will allow Harvest One to execute on its strategy to become an industry-leading global health and wellness company.”

“Throughout my career I have worked to manage people and culture within multiple organizations, particularly through times of change and mergers.  I could not be more thrilled to join Harvest One to help to ensure efficiency, value, and organizational optimization of the company in this rapidly changing industry, with the expanding reach of Harvest One’s national and international interests,” said Deb Milimaka Miles.

The Company has granted an aggregate of 2,415,000 stock options under its incentive stock option plan, to certain officers, directors, employees and consultants of the Company. Each stock option entitles the holder to purchase one common share at an exercise price of $0.85 for a period of five years following the grant date.

ABOUT HARVEST ONE CANNABIS INC.

Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company’s range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer), and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

SOURCE Harvest One Cannabis Inc.

For further information: Colin Clancy, Investor Relations, cclancy@harvestone.com, 1-877-915-7934

Click here to connect with Harvest One (TSXV:HVT) for an Investor Presentation.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less